Your browser doesn't support javascript.
loading
Patterns and predictors of referral to the specialized chronic lymphocytic leukemia clinic in Manitoba, Canada.
Righolt, Christiaan H; Zhang, Geng; Gibson, Spencer B; Johnston, James B; Banerji, Versha; Mahmud, Salaheddin M.
Affiliation
  • Righolt CH; Vaccine and Drug Evaluation Centre, Department of Community Health Sciences, University of Manitoba, 337-750 McDermot Avenue, Winnipeg, MB, Canada R3E 0T5.
  • Zhang G; Vaccine and Drug Evaluation Centre, Department of Community Health Sciences, University of Manitoba, 337-750 McDermot Avenue, Winnipeg, MB, Canada R3E 0T5.
  • Gibson SB; Research Institute of Oncology and Hematology, CancerCare Manitoba, Winnipeg, Manitoba, Canada; Department of Hematology and Oncology, CancerCare Manitoba, Winnipeg, Manitoba, Canada.
  • Johnston JB; Research Institute of Oncology and Hematology, CancerCare Manitoba, Winnipeg, Manitoba, Canada; Department of Hematology and Oncology, CancerCare Manitoba, Winnipeg, Manitoba, Canada; Department Internal Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.
  • Banerji V; Research Institute of Oncology and Hematology, CancerCare Manitoba, Winnipeg, Manitoba, Canada; Department of Hematology and Oncology, CancerCare Manitoba, Winnipeg, Manitoba, Canada; Department Internal Medicine, University of Manitoba, Winnipeg, Manitoba, Canada; Department of Biochemistry and Med
  • Mahmud SM; Vaccine and Drug Evaluation Centre, Department of Community Health Sciences, University of Manitoba, 337-750 McDermot Avenue, Winnipeg, MB, Canada R3E 0T5. Electronic address: Salah.Mahmud@gmail.com.
Cancer Epidemiol ; 81: 102279, 2022 12.
Article in En | MEDLINE | ID: mdl-36279643
ABSTRACT

BACKGROUND:

Better CLL patient survival has been reported for specialized CLL clinics/hematologists (compared to other CLL patients). It is possible that improved survival is driven by a better prognosis of referred patients.

METHODS:

We used logistic regression to calculate the odds ratios (ORs) and 95 % confidence intervals 95 %CIs) of the association between patient characteristics and CLL referral of all persons diagnosed in 2005-2016 with a pathologically-confirmed CLL or SLL.

RESULTS:

Two-thirds of 1293 patients were referred to the CLL clinic. Referred patients were younger (16 % vs 44 % were 80 +) and in better health (47 % vs 56 % with a chronic diseases) than non-referred patients. Referral increased over time in 2005-2010, about 60 % of patients were referred; in 2011-2016, this increased to 76 %. Gender did not affect referral (the OR for females is 1.0, 95 %CI 0.8-1.2), but age played a major role; CLL patients diagnosed at age 80 + were less likely to be referred than patients diagnosed < 60, 0.2 (0.1-0.3).

CONCLUSION:

Because referral to Manitoba's specialized CLL clinic is associated with age and the patient's overall health before referral, one should be careful in interpreting differences in outcomes between CLL patients based on referral status alone.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Referral and Consultation / Leukemia, Lymphocytic, Chronic, B-Cell Type of study: Prognostic_studies / Risk_factors_studies Limits: Aged80 / Female / Humans Country/Region as subject: America do norte Language: En Year: 2022 Type: Article

Full text: 1 Database: MEDLINE Main subject: Referral and Consultation / Leukemia, Lymphocytic, Chronic, B-Cell Type of study: Prognostic_studies / Risk_factors_studies Limits: Aged80 / Female / Humans Country/Region as subject: America do norte Language: En Year: 2022 Type: Article